Once-daily injections of liraglutide, a long-acting, acylated, glucagon-like peptide 1 analog, have proven to be effective in the treatment of patients with type 2 diabetes.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Liraglutide effective in treating type 2 diabetes

Newsletter